EW 240816 67.50P (EW240816P67500) Stock Options, News & Quotes

US OptionsDetailed Quotes

EW240816P67500

Watchlist

6.25
-0.05-0.79%

15min DelayClose Jul 26 15:59 ET

6.25High6.25Low

Intraday

5D
Daily

News

Market Whales and Their Recent Bets on Edwards Lifesciences Options
BenzingaJul 26 13:01 ET
Express News | Barclays Maintains Overweight on Edwards Lifesciences, Lowers Price Target to $90
BenzingaJul 26 11:51 ET
Express News | Edward Lifesciences Shares Are Trading Higher, Slightly Rebounding After Falling When the Company Reported Mixed Q3 Results and Issued Weak Guidance This Week. Additionally, Goldman Sachs Maintained a Buy Rating on the Stock
BenzingaJul 26 11:14 ET
Edwards Lifesciences Is Maintained at Buy by Goldman Sachs
Dow JonesJul 26 10:24 ET
Edwards Lifesciences Price Target Cut to $91.00/Share From $107.00 by Goldman Sachs
Dow JonesJul 26 10:24 ET · Ratings
Edwards Lifesciences Analyst Ratings
BenzingaJul 26 10:13 ET · Ratings

Comments

Moomoo Recap US

Jul 25 15:48

Columns Nvidia, Alphabet, Microsoft, Drag S&P, Nasdaq Lower | Wall Street Today

by Luzi Ann Santos | moomoo News
Google parent $Alphabet-A(GOOGL.US)$, $Microsoft(MSFT.US)$ and Nvidia led the slump in Magnificent Seven stocks, dragging down the S&P 500 and the Nasdaq amid mounting speculation big money is moving from this year's biggest gainers to unloved equities.
The $S&P 500 Index(.SPX.US)$ slipped 0.5% to close Thursday at 5,399.22, while the tech-heavy $Nasdaq Composite Index(.IXIC.US)$ declined 0.9...

Big tech earnings disappoint, US stocks dips: Who's the next hope?

Kevin Travers

Jul 25 10:58

Columns Market Tech like Nvidia, Tesla Climbing Again | Herd on Wall St.

Good afternoon, traders. Happy Thursday, July 25th. The market is turning sideways, but big tech is climbing back up after dropping Wednesday: earnings season is hurting stock gains enjoyed so far this year.
My name is Kevin Travers, here are stories from the herd on Wall St today.
$Ford Motor(F.US)$ stock is moving 18% lower on Thursday after the company missed analyst EPS estimates for the 2024 fiscal year's second quarter. The co...

Herd on Wall Street: mooving news stories and updates!

Ho Lee Fuk

Jul 25 07:45

$Edwards Lifesciences(EW.US)$ should go back up in a few months

Jerry Kronenberg

Jul 24 16:43

Columns Edwards Lifesciences Tanks 15% After Hours on Fiscal Q2 Revenue Miss and $1.2 Billion of Acquisitions

$Edwards Lifesciences(EW.US)$ fell more than 15% after hours Wednesday after the medical-device developer missed analyst expectations for fiscal Q2 revenues and announced $1.2 billion in acquisitions.
EW sank 15.4% to $73.55 shortly before 5:30 p.m. ET after the firm reported $1.39 billion in net sales for the three months ended June 30. That missed the $1.65 billion consensus that analysts had r...

Moomoo AI

Mar 5 12:28

Edwards Lifesciences' impressive ROCE history and its ability to generate high returns on increasing amounts of capital employed indicate strong fundamentals. This warrants further research into the stock despite it being more 'expensive' than before.

Edwards Lifesciences (NYSE:EW) Is Aiming To Keep Up Its Impressive Returns